GlassScriptPhysician profile
Leonid Kotkin
NPI 1326035825
$6,031.30
in general payments reported to CMS, 2019-2025
25 companies · $2,720 in 2025
The $2,720 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $273 · 2021: $192 · 2022: $71.86 · 2023: $1,642 · 2025: $2,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,320 · Food and Beverage: $41.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,320.00 |
| Food and Beverage | $41.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gyrus Acmi, INC. | $2,700.00 | 2025 | Soltive |
| Olympus Medical Systems Corporation | $1,620.00 | 2023 | Oes Choledochofiberscope |
| Dentsply Ih INC. | $422.27 | 2019-2022 | |
| Astellas Pharma US INC | $359.69 | 2019-2020 | |
| Therapeuticsmd, INC. | $147.11 | 2019 | |
| Neotract INC. | $116.97 | 2019-2020 | |
| Antares Pharma, INC. | $108.16 | 2019-2023 | Nocdurna, Xyosted, Tlando |
| Pfizer INC. | $93.99 | 2019-2020 | |
| Teleflex LLC | $59.84 | 2021 | |
| Abbvie INC. | $49.80 | 2022-2025 | |
| Janssen Biotech, INC. | $46.32 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $38.08 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Bard Access Systems, INC. | $27.27 | 2019 | |
| Rochester Medical Corporation | $23.56 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.52 | 2021 | |
| Urovant Sciences INC | $21.23 | 2021 | |
| Coloplast Corp | $19.57 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $19.39 | 2019 | |
| Ferring Pharmaceuticals INC. | $19.13 | 2019 | |
| Acerus Pharmaceuticals Corporation | $18.98 | 2020 | |
| Boston Scientific Corporation | $17.44 | 2019 | |
| Blue Earth Diagnostics | $16.75 | 2020 | |
| Allergan, INC. | $16.40 | 2020 | |
| Sun Pharmaceutical Industries INC. | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonid Kotkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.